|
Back to Home » June 2019 News » Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials |
Novartis Shows Growing Strength in Lung Cancer Innovation with New Capmatinib Investigational Data and Novel Canakinumab Clinical Trials |
June 03, 2019
BASEL, Switzerland, June 3, 2019 /PRNewswire/ -- Novartis announced today new data and clinical trial updates in NSCLC at the ASCO 2019 Annual Meeting. This includes primary efficacy results from the GEOMETRY mono-1 Phase II clinical trial demonstrating that investigational MET inhibitor...
Source URL: https://prnmedia.prnewswire.com:443/news-releases/novartis-shows-growing-strength-in-lung-cancer-innovation-with-new-capmatinib-investigational-data-and-novel-canakinumab-clinical-trials-300860389.html
|
|
|
|
